Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-08

Clinical Trial Update: Cervical Preparation With Mifepristone Prior to Osmotic Dilators [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cervical preparation with mifepristone before osmotic dilators for second trimester abortion was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mifepristone (mifepristone)

Snippet

Sponsor: University of California, Davis | Conditions: Second Trimester Abortion | Phase 2 | Status: TERMINATED | Results posted: 2022-06-08